Germany has developed a model of social health insurance for financing
healthcare. The basic characteristics of this model are compulsory me
mbership, income-dependent contributions paid by employers and employe
es, a comprehensive package of healthcare entitlements, stringent gove
rnment regulation and implementation by not-for-profit health insurers
- the sickness funds - which operate under public law. Since the mid-
1970s, when health care cost containment gradually evolved as a new is
sue in German healthcare policy-making, a long series of reform progra
mmes have been initiated. Two recent development can be noted: the int
roduction of market competition in health insurance and the introducti
on of fixed budgets. Market competition in health insurance is now an
explicit policy tool in Germany. This article analyses the German heal
thcare system, the history of healthcare reforms and the current healt
hcare acts. Special emphasis is given to the German drug market and it
s regulation. The paper describes the present cost-containment policy
for pharmaceutical products, especially the global budget concept whic
h was introduced for medicines and patients' copayments.